Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Association of four DNA polymorphisms with acute rejection after kidney transplantation

Grinyo, Josep ; Vanrenterghem, Yves ; Nashan, Bjoern ; Vincenti, Flavio ; Ekberg, Henrik LU ; Lindpaintner, Klaus ; Rashford, Michelle ; Nasmyth-Miller, Clare ; Voulgari, Athina and Spleiss, Olivia , et al. (2008) In Transplant International 21(9). p.879-891
Abstract
Renal transplant outcomes exhibit large inter-individual variability, possibly on account of genetic variation in immune-response mediators and genes influencing the pharmacodynamics/pharmacokinetics of immunosuppressants. We examined 21 polymorphisms from 10 genes in 237 de novo renal transplant recipients participating in an open-label, multicenter study [Cyclosporine Avoidance Eliminates Serious Adverse Renal-toxicity (CAESAR)] investigating renal function and biopsy-proven acute rejection (BPAR) with different cyclosporine A regimens and mycophenolate mofetil. Genes were selected for their immune response and pharmacodynamic/pharmacokinetic relevance and were tested for association with BPAR. Four polymorphisms were significantly... (More)
Renal transplant outcomes exhibit large inter-individual variability, possibly on account of genetic variation in immune-response mediators and genes influencing the pharmacodynamics/pharmacokinetics of immunosuppressants. We examined 21 polymorphisms from 10 genes in 237 de novo renal transplant recipients participating in an open-label, multicenter study [Cyclosporine Avoidance Eliminates Serious Adverse Renal-toxicity (CAESAR)] investigating renal function and biopsy-proven acute rejection (BPAR) with different cyclosporine A regimens and mycophenolate mofetil. Genes were selected for their immune response and pharmacodynamic/pharmacokinetic relevance and were tested for association with BPAR. Four polymorphisms were significantly associated with BPAR. The ABCB1 2677T allele tripled the odds of developing BPAR (OR: 3.16, 95% CI [1.50-6.67]; P = 0.003), as did the presence of at least one IMPDH2 3757C allele (OR: 3.39, 95% CI [1.42-8.09]; P = 0.006). BPAR was almost fivefold more likely in patients homozygous for IL-10 -592A (OR: 4.71, 95% CI [1.52-14.55]; P = 0.007) and twice as likely in patients with at least one A allele of TNF-alpha G-308A (OR: 2.18, 95% CI [1.08-4.41]; P = 0.029). There were no statistically significant interactions between polymorphisms, or the different treatment regimens. Variation in genes of immune response and pharmacodynamic/pharmacokinetic relevance may be important in understanding acute rejection after renal transplant. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
single nucleotide polymorphism, acute rejection, kidney transplantation
in
Transplant International
volume
21
issue
9
pages
879 - 891
publisher
Springer
external identifiers
  • wos:000258381400008
  • scopus:49649106273
  • pmid:18444945
ISSN
1432-2277
DOI
10.1111/j.1432-2277.2008.00679.x
language
English
LU publication?
yes
id
397dfefb-233d-4281-98d3-dc5d7845ab51 (old id 1252116)
date added to LUP
2016-04-01 13:28:12
date last changed
2022-01-27 19:25:18
@article{397dfefb-233d-4281-98d3-dc5d7845ab51,
  abstract     = {{Renal transplant outcomes exhibit large inter-individual variability, possibly on account of genetic variation in immune-response mediators and genes influencing the pharmacodynamics/pharmacokinetics of immunosuppressants. We examined 21 polymorphisms from 10 genes in 237 de novo renal transplant recipients participating in an open-label, multicenter study [Cyclosporine Avoidance Eliminates Serious Adverse Renal-toxicity (CAESAR)] investigating renal function and biopsy-proven acute rejection (BPAR) with different cyclosporine A regimens and mycophenolate mofetil. Genes were selected for their immune response and pharmacodynamic/pharmacokinetic relevance and were tested for association with BPAR. Four polymorphisms were significantly associated with BPAR. The ABCB1 2677T allele tripled the odds of developing BPAR (OR: 3.16, 95% CI [1.50-6.67]; P = 0.003), as did the presence of at least one IMPDH2 3757C allele (OR: 3.39, 95% CI [1.42-8.09]; P = 0.006). BPAR was almost fivefold more likely in patients homozygous for IL-10 -592A (OR: 4.71, 95% CI [1.52-14.55]; P = 0.007) and twice as likely in patients with at least one A allele of TNF-alpha G-308A (OR: 2.18, 95% CI [1.08-4.41]; P = 0.029). There were no statistically significant interactions between polymorphisms, or the different treatment regimens. Variation in genes of immune response and pharmacodynamic/pharmacokinetic relevance may be important in understanding acute rejection after renal transplant.}},
  author       = {{Grinyo, Josep and Vanrenterghem, Yves and Nashan, Bjoern and Vincenti, Flavio and Ekberg, Henrik and Lindpaintner, Klaus and Rashford, Michelle and Nasmyth-Miller, Clare and Voulgari, Athina and Spleiss, Olivia and Truman, Matthew and Essioux, Laurent}},
  issn         = {{1432-2277}},
  keywords     = {{single nucleotide polymorphism; acute rejection; kidney transplantation}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{879--891}},
  publisher    = {{Springer}},
  series       = {{Transplant International}},
  title        = {{Association of four DNA polymorphisms with acute rejection after kidney transplantation}},
  url          = {{http://dx.doi.org/10.1111/j.1432-2277.2008.00679.x}},
  doi          = {{10.1111/j.1432-2277.2008.00679.x}},
  volume       = {{21}},
  year         = {{2008}},
}